Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) Target Price at $80.10

Henry Schein, Inc. (NASDAQ:HSIC) has been assigned an average rating of “Moderate Buy” from the twelve research firms that are presently covering the company, MarketBeat reports. Six research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $80.10.

Several research analysts have commented on the stock. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Mizuho initiated coverage on Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective for the company. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Barrington Research lifted their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, January 30th.

Insider Activity

In related news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.14% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Sequoia Financial Advisors LLC boosted its stake in shares of Henry Schein by 7.2% during the 4th quarter. Sequoia Financial Advisors LLC now owns 6,109 shares of the company’s stock worth $423,000 after acquiring an additional 412 shares in the last quarter. HighTower Advisors LLC boosted its position in shares of Henry Schein by 242.9% in the 4th quarter. HighTower Advisors LLC now owns 43,347 shares of the company’s stock valued at $3,000,000 after purchasing an additional 30,706 shares during the period. AGF Management Ltd. purchased a new position in Henry Schein in the 4th quarter worth about $796,000. Daiwa Securities Group Inc. raised its holdings in Henry Schein by 5.4% during the 4th quarter. Daiwa Securities Group Inc. now owns 16,486 shares of the company’s stock worth $1,141,000 after buying an additional 850 shares during the period. Finally, Isthmus Partners LLC raised its holdings in Henry Schein by 2.8% during the 4th quarter. Isthmus Partners LLC now owns 9,888 shares of the company’s stock worth $684,000 after buying an additional 266 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Henry Schein Stock Down 1.1 %

Henry Schein stock opened at $79.00 on Wednesday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein has a one year low of $63.67 and a one year high of $82.63. The company has a 50-day simple moving average of $73.70 and a 200-day simple moving average of $71.80. The firm has a market capitalization of $9.85 billion, a P/E ratio of 32.51, a P/E/G ratio of 2.21 and a beta of 0.91.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.